These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31845444)

  • 1. Bitter melon fruit extract has a hypoglycemic effect and reduces hepatic lipid accumulation in ob/ob mice.
    Dwijayanti DR; Shimada T; Ishii T; Okuyama T; Ikeya Y; Mukai E; Nishizawa M
    Phytother Res; 2020 Jun; 34(6):1338-1346. PubMed ID: 31845444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bitter melon fruit extract enhances intracellular ATP production and insulin secretion from rat pancreatic
    Shimada T; Kato F; Dwijayanti DR; Nagata T; Kinoshita A; Okuyama T; Nishizawa M; Mukai E
    Br J Nutr; 2022 Feb; 127(3):377-383. PubMed ID: 33762029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of bitter melon (Momordica charantia) against insulin resistance and diabetes are associated with the inhibition of NF-κB and JNK pathways in high-fat-fed OLETF rats.
    Yang SJ; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY
    J Nutr Biochem; 2015 Mar; 26(3):234-40. PubMed ID: 25488547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
    Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
    Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
    J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sialic acid changes in non-insulin-dependant diabetes mellitus (NIDDM) patients following bitter melon (Momordica charantia) and rosiglitazone (Avandia) treatment.
    Inayat-ur-Rahman ; Malik SA; Bashir M; Khan R; Iqbal M
    Phytomedicine; 2009 May; 16(5):401-5. PubMed ID: 19362455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets.
    Jayasooriya AP; Sakono M; Yukizaki C; Kawano M; Yamamoto K; Fukuda N
    J Ethnopharmacol; 2000 Sep; 72(1-2):331-6. PubMed ID: 10967491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
    Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
    Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of Charantin and Expression of Triterpenoid Biosynthesis Genes in Bitter Melon (Momordica charantia).
    Cuong DM; Jeon J; Morgan AMA; Kim C; Kim JK; Lee SY; Park SU
    J Agric Food Chem; 2017 Aug; 65(33):7240-7249. PubMed ID: 28737900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
    Fuangchan A; Sonthisombat P; Seubnukarn T; Chanouan R; Chotchaisuwat P; Sirigulsatien V; Ingkaninan K; Plianbangchang P; Haines ST
    J Ethnopharmacol; 2011 Mar; 134(2):422-8. PubMed ID: 21211558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.
    Shih CC; Shlau MT; Lin CH; Wu JB
    Phytother Res; 2014 Mar; 28(3):363-71. PubMed ID: 23610006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
    Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
    Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.
    Yibchok-anun S; Adisakwattana S; Yao CY; Sangvanich P; Roengsumran S; Hsu WH
    Biol Pharm Bull; 2006 Jun; 29(6):1126-31. PubMed ID: 16755004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts of Momordica charantia suppress postprandial hyperglycemia in rats.
    Uebanso T; Arai H; Taketani Y; Fukaya M; Yamamoto H; Mizuno A; Uryu K; Hada T; Takeda E
    J Nutr Sci Vitaminol (Tokyo); 2007 Dec; 53(6):482-8. PubMed ID: 18202535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
    Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
    J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet.
    Shih CC; Lin CH; Lin WL
    Diabetes Res Clin Pract; 2008 Aug; 81(2):134-43. PubMed ID: 18550200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L.
    Shivanagoudra SR; Perera WH; Perez JL; Athrey G; Sun Y; Wu CS; Jayaprakasha GK; Patil BS
    Bioorg Med Chem; 2019 Jul; 27(14):3097-3109. PubMed ID: 31196754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.